Translational Research

Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read More

ASPIRE to Innovate Postdoctoral Fellow Catherine Leasure identifies the issues plaguing drug development. Leasure and Gregor Neuert argue that conventional dose-response studies fail to mirror the complex reality of how drugs behave in the human body. Read More